STOCK TITAN

[EFFECT] OKYO Pharma Ltd SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 10, 2026 9:00 A.M.
Form: F-3
CIK: 0001849296
Company Name: OKYO Pharma Ltd
File Number: 333-293145